tiprankstipranks
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Financial Statements

Compare
2 Followers

MaaT Pharma Financial Overview

MaaT Pharma's market cap is currently €88.74M. The company's EPS TTM is €-2.025; its P/E ratio is ―; MaaT Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 2.23M€ 1.43M€ 972.00K€ 0.00€ 89.30K
Gross Profit€ 1.66M€ 1.09M€ 806.00K€ -164.00K€ -7.70K
Operating Income€ -19.94M€ -13.56M€ -8.89M€ -5.25M€ -4.96M
EBITDA€ -19.74M€ -13.31M€ -8.71M€ -6.58M€ -6.76M
Net Income€ -19.72M€ -13.87M€ -9.14M€ -5.35M€ -6.65M
Balance Sheet
Cash & Short-Term Investments€ 24.31M€ 35.31M€ 43.30M€ 19.91M€ 5.41M
Total Assets€ 42.93M€ 44.73M€ 49.42M€ 24.28M€ 8.17M
Total Debt€ 14.07M€ 11.36M€ 5.81M€ 6.08M€ 10.46M
Net Debt€ -10.21M€ -23.89M€ -37.50M€ -13.84M€ 5.05M
Total Liabilities€ 22.46M€ 17.91M€ 9.56M€ 8.34M€ 12.73M
Stockholders' Equity€ 20.47M€ 26.81M€ 39.86M€ 15.94M€ -4.57M
Cash Flow
Free Cash Flow€ -19.76M€ -13.27M€ -8.17M€ -6.13M€ -5.15M
Operating Cash Flow€ -18.67M€ -12.61M€ -7.93M€ -5.81M€ -5.02M
Investing Cash Flow€ -440.00K€ -815.00K€ -238.00K€ -523.00K€ -154.00K
Financing Cash Flow€ 8.14M€ 5.36M€ 31.56M€ 20.84M€ 6.98M
Currency in EUR

MaaT Pharma Earnings and Revenue History

MaaT Pharma Debt to Assets

MaaT Pharma Cash Flow

MaaT Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis